Equillium (EQ) Other Non-Current Liabilities (2017 - 2021)
Equillium (EQ) reported Other Non-Current Liabilities of $17000.0 for Q3 2021, down 76.06% year-over-year from $71000.0 in Q3 2020, and little changed quarter-over-quarter from $17000.0 in Q2 2021.
Equillium (EQ) Other Non-Current Liabilities (2017 - 2021) Analysis & Trends
Equillium (EQ) has 5 years of Other Non-Current Liabilities data on file, last reported at $17000.0 in Q3 2021.
- Other Non-Current Liabilities for Q3 2021 came in at $17000.0, down 76.06% year-over-year; the trailing twelve-month figure through Sep 2021 was $17000.0 (down 76.06% YoY), and the FY2020 annual result was $54000.0, down 57.48% from the prior year.
- Other Non-Current Liabilities steadied at $17000.0 in Q3 2021 per EQ's latest filing, from $17000.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $775842.0 in Q4 2017 and troughed at $17000.0 in Q2 2021.
- A 5-year average of $149130.5 and a median of $99000.0 in 2020 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2019 and 2021: Other Non-Current Liabilities fell 1.83% in 2019, then tumbled 81.11% in 2021.
- A 5-year view of Other Non-Current Liabilities shows it stood at $775842.0 in 2017, then sank by 74.22% to $200000.0 in 2018, then tumbled by 36.5% to $127000.0 in 2019, then sank by 57.48% to $54000.0 in 2020, then slumped by 68.52% to $17000.0 in 2021.
- Business Quant data shows EQ's Other Non-Current Liabilities at $17000.0 in Q3 2021, $17000.0 in Q2 2021, and $35000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 17,000.00 |
| Jun 30, 2021 | 17,000.00 |
| Mar 31, 2021 | 35,000.00 |
| Dec 31, 2020 | 54,000.00 |
| Sep 30, 2020 | 71,000.00 |
| Jun 30, 2020 | 90,000.00 |
| Mar 31, 2020 | 108,000.00 |
| Dec 31, 2019 | 127,000.00 |
| Sep 30, 2019 | 146,000.00 |
| Dec 31, 2018 | 200,000.00 |
| Sep 30, 2018 | 148,724.00 |
| Dec 31, 2017 | 775,842.00 |